(Q33650188)

28 July 2017

title

Long-term postmenopausal hormone therapy and endometrial cancer (English)

1 reference

28 July 2017

1 reference

5

Leslie Bernstein

1 reference

28 July 2017

3

Pamela L Horn-Ross

1 reference

28 July 2017

6

Giske Ursin

1 reference

28 July 2017

4

Claire Templeman

1 reference

28 July 2017

2

Malcolm C Pike

1 reference

28 July 2017

1

Pedram Razavi

1 reference

28 July 2017

language of work or name

1 reference

19 January 2010

1 reference

Cancer Epidemiology, Biomarkers & Prevention

28 July 2017

published in

1 reference

28 July 2017

volume

19

1 reference

28 July 2017

issue

2

1 reference

28 July 2017

page(s)

475-483

1 reference

Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2821215

Endometrial cancer and hormone-replacement therapy in the Million Women Study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2821215

Hormone therapy in postmenopausal women and risk of endometrial hyperplasia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2821215

High breast cancer incidence rates among California teachers: results from the California Teachers Study (United States).

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2821215

Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2821215

Estrogen-progestin replacement therapy and endometrial cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2821215

Hormone replacement therapy and endometrial cancer risk: a meta-analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2821215

Extraglandular oestrogen formation and serum binding of oestradiol: relationship to cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2821215

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2821215

The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2821215

Pictorially assisted recall of past hormone use in case-control studies.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2821215

The modifying effect of progestogen on the response of the post-menopausal endometrium to exogenous oestrogens

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2821215

Endometrial Histology and Biochemistry in Climacteric Women during Oestrogen and Oestrogen/Progestogen Therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2821215

Long-term use of postmenopausal estrogen and progestin hormone therapies and the risk of endometrial cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2821215

Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2821215

Endometrial effects of tibolone.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2821215

Effects of tibolone and continuous combined conjugated equine estrogen/medroxyprogesterone acetate on the endometrium and vaginal bleeding: results of the OPAL study.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2821215

Apoptosis, proliferation, and sex steroid receptors in postmenopausal endometrium before and during HRT.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2821215

Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2821215

Patterns of postmenopausal progestin use with estrogen in relation to endometrial cancer (United States)

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2821215

The endometrial response to sequential and continuous combined oestrogen-progestogen replacement therapy

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2821215

Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2821215

Body Mass and Endometrial Cancer Risk by Hormone Replacement Therapy and Cancer Subtype

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2821215

Anthropometric factors and risk of endometrial cancer: the European prospective investigation into cancer and nutrition

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2821215

Effect of hormone replacement therapy on postmenopausal endometrial bleeding

30 October 2018

1 reference

12 December 2020

Estrogens, progestins, and risk of breast cancer

1 reference

12 December 2020

Hormone replacement therapy and endometrial cancer in Ontario, Canada

1 reference

12 December 2020

Continuous combined hormone replacement therapy and risk of endometrial cancer

1 reference

12 December 2020

The relationship between the extraglandular production of estrone and the occurrence of endometrial neoplasia

1 reference

12 December 2020

Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer

1 reference

12 December 2020

Progestogen modification of endometrial histology in menopasual women

1 reference

12 December 2020

Estrogen replacement therapy and endometrial cancer risk: unresolved issues. The Endometrial Cancer Collaborative Group

1 reference

12 December 2020

Risk of Endometrial Cancer Following Estrogen Replacement With and Without Progestins

1 reference

12 December 2020

Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women

1 reference

12 December 2020

10.1158/1055-9965.EPI-09-0712

Identifiers

DOI

1 reference

28 July 2017

1 reference

28 July 2017

1 reference